ULTRAGENYX PHARMACEUTICAL INC. Increase (Decrease) in Prepaid Expense and Other Assets
ULTRAGENYX PHARMACEUTICAL INC. (RARE) reported Increase (Decrease) in Prepaid Expense and Other Assets of -$16.58 million for the 9-month period ending 2023-09-30, per its 10-Q filed 2023-11-03.
Discontinued › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets · last filed 2023-11-03
- ULTRAGENYX PHARMACEUTICAL INC. increase (decrease) in prepaid expense and other assets for the quarter ending 2023-09-30 was -$4.99M.
- ULTRAGENYX PHARMACEUTICAL INC. increase (decrease) in prepaid expense and other assets for the quarter ending 2023-06-30 was -$12.11M, a 176.09% decline year-over-year.
- ULTRAGENYX PHARMACEUTICAL INC. increase (decrease) in prepaid expense and other assets for the quarter ending 2023-03-31 was $519.00K.
- ULTRAGENYX PHARMACEUTICAL INC. increase (decrease) in prepaid expense and other assets for the quarter ending 2022-12-31 was -$3.24M, a 114.38% decline year-over-year.
- ULTRAGENYX PHARMACEUTICAL INC. increase (decrease) in prepaid expense and other assets for fiscal 2022 was -$3.80M, a 112.87% decline from fiscal 2021.
- ULTRAGENYX PHARMACEUTICAL INC. increase (decrease) in prepaid expense and other assets for fiscal 2021 was $29.51M.
- ULTRAGENYX PHARMACEUTICAL INC. increase (decrease) in prepaid expense and other assets for fiscal 2020 was -$2.75M, a 133.45% decline from fiscal 2019.
- ULTRAGENYX PHARMACEUTICAL INC. increase (decrease) in prepaid expense and other assets for fiscal 2019 was $8.22M, a 42.49% decline from fiscal 2018.
| Period end | Increase (Decrease) in Prepaid Expense and Other Assets 3 month | Increase (Decrease) in Prepaid Expense and Other Assets 3 month as first filed | Increase (Decrease) in Prepaid Expense and Other Assets 6 month | Increase (Decrease) in Prepaid Expense and Other Assets 6 month as first filed | Increase (Decrease) in Prepaid Expense and Other Assets 9 month | Increase (Decrease) in Prepaid Expense and Other Assets 9 month as first filed | Increase (Decrease) in Prepaid Expense and Other Assets 12 month | Increase (Decrease) in Prepaid Expense and Other Assets 12 month as first filed | Increase (Decrease) in Prepaid Expense and Other Assets 47 month |
|---|---|---|---|---|---|---|---|---|---|
| 2023-09-30 | -$4.99M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-03 | -$17.10M derived: sum of 2 quarters · filed 2023-11-03 | -$16.58M 10-Q · filed 2023-11-03 | -$19.82M derived: sum of 4 quarters · filed 2023-11-03 | |||||
| 2023-06-30 | -$12.11M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-04 | -$11.59M 10-Q · filed 2023-08-04 | -$14.83M derived: sum of 3 quarters · filed 2023-08-04 | -$22.18M derived: sum of 4 quarters · filed 2023-11-03 | |||||
| 2023-03-31 | $519.00K 10-Q · filed 2023-05-05 | -$2.72M derived: sum of 2 quarters · filed 2023-05-05 | -$10.07M derived: sum of 3 quarters · filed 2023-11-03 | $5.85M derived: sum of 4 quarters · filed 2023-11-03 | |||||
| 2022-12-31 | -$3.24M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-17 | -$10.59M derived: sum of 2 quarters · filed 2023-11-03 | $5.33M derived: sum of 3 quarters · filed 2023-11-03 | -$3.80M 10-K · filed 2023-02-17 | |||||
| 2022-09-30 | -$7.35M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-03 | $8.57M derived: sum of 2 quarters · filed 2023-11-03 | -$558.00K 10-Q · filed 2023-11-03 | $21.97M derived: sum of 4 quarters · filed 2023-11-03 | |||||
| 2022-06-30 | $15.92M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-04 | $6.79M 10-Q · filed 2023-08-04 | $29.32M derived: sum of 3 quarters · filed 2023-08-04 | $27.30M derived: sum of 4 quarters · filed 2023-08-04 | |||||
| 2022-03-31 | -$9.13M 10-Q · filed 2023-05-05 | $13.40M derived: sum of 2 quarters · filed 2023-05-05 | $11.38M derived: sum of 3 quarters · filed 2023-05-05 | $9.73M derived: sum of 4 quarters · filed 2023-05-05 | |||||
| 2021-12-31 | $22.53M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-17 | $20.51M derived: sum of 2 quarters · filed 2023-02-17 | $18.85M derived: sum of 3 quarters · filed 2023-02-17 | $29.51M 10-K · filed 2023-02-17 | |||||
| 2021-09-30 | -$2.02M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-03 | -$3.68M derived: sum of 2 quarters · filed 2022-11-03 | $6.98M 10-Q · filed 2022-11-03 | -$8.23M derived: sum of 4 quarters · filed 2023-02-17 | |||||
| 2021-06-30 | -$1.65M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-07-29 | $9.00M 10-Q · filed 2022-07-29 | -$6.21M derived: sum of 3 quarters · filed 2023-02-17 | $118.00K derived: sum of 4 quarters · filed 2023-02-17 | |||||
| 2021-03-31 | $10.66M 10-Q · filed 2022-05-06 | -$4.55M derived: sum of 2 quarters · filed 2023-02-17 | $1.77M derived: sum of 3 quarters · filed 2023-02-17 | -$7.19M derived: sum of 4 quarters · filed 2023-02-17 | |||||
| 2020-12-31 | -$15.21M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-17 | -$8.88M derived: sum of 2 quarters · filed 2023-02-17 | -$17.84M derived: sum of 3 quarters · filed 2023-02-17 | -$2.75M 10-K · filed 2023-02-17 | |||||
| 2020-09-30 | $6.33M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-03 | -$2.63M derived: sum of 2 quarters · filed 2021-11-03 | $12.46M 10-Q · filed 2021-11-03 | $14.80M derived: sum of 4 quarters · filed 2022-02-15 | |||||
| 2020-06-30 | -$8.96M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-03 | $6.14M 10-Q · filed 2021-08-03 | $8.48M derived: sum of 3 quarters · filed 2022-02-15 | $11.10M derived: sum of 4 quarters · filed 2022-02-15 | |||||
| 2020-03-31 | $15.10M 10-Q · filed 2021-05-05 | $17.44M derived: sum of 2 quarters · filed 2022-02-15 | $20.06M derived: sum of 3 quarters · filed 2022-02-15 | $21.90M derived: sum of 4 quarters · filed 2022-02-15 | |||||
| 2019-12-31 | $2.34M derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-15 | $4.96M derived: sum of 2 quarters · filed 2022-02-15 | $6.80M derived: sum of 3 quarters · filed 2022-02-15 | $8.22M 10-K · filed 2022-02-15 | |||||
| 2019-09-30 | $2.62M derived: 10-Q 9 month − 10-Q 6 month · filed 2020-10-27 | $4.46M derived: sum of 2 quarters · filed 2020-10-27 | $5.87M 10-Q · filed 2020-10-27 | $6.95M 10-Q · filed 2019-11-06 | -$221.00K derived: sum of 4 quarters · filed 2021-02-12 | ||||
| 2019-06-30 | $1.84M derived: 10-Q 6 month − 10-Q 3 month · filed 2020-07-30 | $3.25M 10-Q · filed 2020-07-30 | $4.26M 10-Q · filed 2019-08-02 | -$2.84M derived: sum of 3 quarters · filed 2021-02-12 | $10.00M derived: sum of 4 quarters · filed 2021-02-12 | ||||
| 2019-03-31 | $1.41M 10-Q · filed 2020-05-07 | $2.36M 10-Q · filed 2019-05-07 | -$4.68M derived: sum of 2 quarters · filed 2021-02-12 | $8.15M derived: sum of 3 quarters · filed 2021-02-12 | $10.45M derived: sum of 4 quarters · filed 2021-02-12 | ||||
| 2018-12-31 | -$6.09M derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-12 | $6.74M derived: sum of 2 quarters · filed 2021-02-12 | $9.03M derived: sum of 3 quarters · filed 2021-02-12 | $14.29M 10-K · filed 2021-02-12 | $13.91M 10-K · filed 2019-02-20 | ||||
| 2018-09-30 | $12.84M derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-06 | $15.13M derived: sum of 2 quarters · filed 2019-11-06 | $20.38M 10-Q · filed 2019-11-06 | $20.01M 10-Q · filed 2018-11-06 | $18.03M derived: sum of 4 quarters · filed 2020-02-14 | ||||
| 2018-06-30 | $2.29M derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-02 | $7.54M 10-Q · filed 2019-08-02 | $22.38M 10-Q · filed 2018-08-03 | $5.19M derived: sum of 3 quarters · filed 2020-02-14 | $4.90M derived: sum of 4 quarters · filed 2020-02-14 | ||||
| 2018-03-31 | $5.25M 10-Q · filed 2019-05-07 | $5.06M 10-Q · filed 2018-05-08 | $2.90M derived: sum of 2 quarters · filed 2020-02-14 | $2.61M derived: sum of 3 quarters · filed 2020-02-14 | $3.07M derived: sum of 4 quarters · filed 2020-02-14 | ||||
| 2017-12-31 | -$2.35M derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-14 | -$2.64M derived: sum of 2 quarters · filed 2020-02-14 | -$2.18M derived: sum of 3 quarters · filed 2020-02-14 | -$3.11M 10-K · filed 2020-02-14 | $3.34M 10-K · filed 2018-02-21 | ||||
| 2017-09-30 | -$291.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-06 | $170.00K derived: sum of 2 quarters · filed 2018-11-06 | -$760.00K 10-Q · filed 2018-11-06 | $554.00K derived: sum of 4 quarters · filed 2019-02-20 | |||||
| 2017-06-30 | $461.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-03 | -$469.00K 10-Q · filed 2018-08-03 | $845.00K derived: sum of 3 quarters · filed 2019-02-20 | $2.12M derived: sum of 4 quarters · filed 2019-02-20 | |||||
| 2017-03-31 | -$930.00K 10-Q · filed 2018-05-08 | $384.00K derived: sum of 2 quarters · filed 2019-02-20 | $1.66M derived: sum of 3 quarters · filed 2019-02-20 | $2.19M derived: sum of 4 quarters · filed 2019-02-20 | |||||
| 2016-12-31 | $1.31M derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-20 | $2.59M derived: sum of 2 quarters · filed 2019-02-20 | $3.12M derived: sum of 3 quarters · filed 2019-02-20 | $7.15M 10-K · filed 2019-02-20 | |||||
| 2016-09-30 | $1.28M derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-03 | $1.80M derived: sum of 2 quarters · filed 2017-11-03 | $5.83M 10-Q · filed 2017-11-03 | $6.57M derived: sum of 4 quarters · filed 2018-02-21 | |||||
| 2016-06-30 | $526.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2017-07-28 | $4.55M 10-Q · filed 2017-07-28 | $5.29M derived: sum of 3 quarters · filed 2018-02-21 | $8.18M derived: sum of 4 quarters · filed 2018-02-21 | |||||
| 2016-03-31 | $4.03M 10-Q · filed 2017-05-05 | $4.76M derived: sum of 2 quarters · filed 2018-02-21 | $7.66M derived: sum of 3 quarters · filed 2018-02-21 | $10.21M derived: sum of 4 quarters · filed 2018-02-21 | |||||
| 2015-12-31 | $736.00K derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-21 | $3.63M derived: sum of 2 quarters · filed 2018-02-21 | $6.18M derived: sum of 3 quarters · filed 2018-02-21 | $7.13M 10-K · filed 2018-02-21 | |||||
| 2015-09-30 | $2.89M derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-08 | $5.45M derived: sum of 2 quarters · filed 2016-11-08 | $6.39M 10-Q · filed 2016-11-08 | $6.78M derived: sum of 4 quarters · filed 2017-02-17 | |||||
| 2015-06-30 | $2.55M derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-09 | $3.50M 10-Q · filed 2016-08-09 | $3.88M derived: sum of 3 quarters · filed 2017-02-17 | $4.49M derived: sum of 4 quarters · filed 2017-02-17 | |||||
| 2015-03-31 | $948.00K 10-Q · filed 2016-05-10 | $1.33M derived: sum of 2 quarters · filed 2017-02-17 | $1.93M derived: sum of 3 quarters · filed 2017-02-17 | $2.64M derived: sum of 4 quarters · filed 2017-02-17 | |||||
| 2014-12-31 | $382.00K derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-17 | $984.00K derived: sum of 2 quarters · filed 2017-02-17 | $1.69M derived: sum of 3 quarters · filed 2017-02-17 | $4.08M 10-K · filed 2017-02-17 | |||||
| 2014-09-30 | $602.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-10 | $1.31M derived: sum of 2 quarters · filed 2015-11-10 | $3.70M 10-Q · filed 2015-11-10 | $3.90M derived: sum of 4 quarters · filed 2016-02-26 | |||||
| 2014-06-30 | $706.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-14 | $3.10M 10-Q · filed 2015-08-14 | $3.30M derived: sum of 3 quarters · filed 2016-02-26 | $3.40M derived: sum of 4 quarters · filed 2016-02-26 | |||||
| 2014-03-31 | $2.39M 10-Q · filed 2015-05-12 | $2.60M derived: sum of 2 quarters · filed 2016-02-26 | $2.70M derived: sum of 3 quarters · filed 2016-02-26 | $3.21M derived: sum of 4 quarters · filed 2016-02-26 | $4.24M 10-Q · filed 2014-05-12 | ||||
| 2013-12-31 | $206.00K derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-26 | $305.00K derived: sum of 2 quarters · filed 2016-02-26 | $817.00K derived: sum of 3 quarters · filed 2016-02-26 | $1.59M 10-K · filed 2016-02-26 | |||||
| 2013-09-30 | $99.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-10 | $611.00K derived: sum of 2 quarters · filed 2014-11-10 | $1.39M 10-Q · filed 2014-11-10 | ||||||
| 2013-06-30 | $512.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2014-08-11 | $1.29M 10-Q · filed 2014-08-11 | |||||||
| 2013-03-31 | $776.00K 10-Q · filed 2014-05-12 | ||||||||
| 2012-12-31 | $47.00K 10-K · filed 2015-03-27 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| OMEROS CORP (OMER) | United States | $1.456B | 5.50 |
| ArriVent BioPharma, Inc. (AVBP) | United States | $1.485B | -10.25 |
| Innoviva, Inc. (INVA) | United States | $1.493B | 4.62 |
| Oric Pharmaceuticals, Inc. (ORIC) | United States | $1.367B | -8.00 |
| ANAPTYSBIO, INC (ANAB) | United States | $1.546B | -60.20 |
| Kailera Therapeutics, Inc. (KLRA) | United States | $1.552B | |
| Kardigan, Inc. (KARD) | United States | $1.346B | |
| Tyra Biosciences, Inc. (TYRA) | United States | $1.337B | -12.83 |
| Bicara Therapeutics Inc. (BCAX) | United States | $1.309B | -10.55 |
| Syndax Pharmaceuticals Inc (SNDX) | United States | $1.606B | -8.82 |